Read more about the article Trump Executive Order, ACA No Immediate Impact Promises Simplification and Freer Markets
Trumpcare, President Donald Trumps first executive order regarding the Affordable Care Act

Trump Executive Order, ACA No Immediate Impact Promises Simplification and Freer Markets

The Trump Executive Order, ACA sends more of a message rather than effecting any immediate change.  It signals a reduction in administrative burden to the American healthcare economy. TrumpCare may…

Continue ReadingTrump Executive Order, ACA No Immediate Impact Promises Simplification and Freer Markets

Expert Witness for Future Medical Costs in Life Care Plans

In our experience, one strategy is to work within the Superior Court or State Court level and then appeal to a higher court perhaps at the Federal level. Some courts have elected not to hear testimony regarding future care costs under the Affordable Care Act, only to find that it is the law of the land and now has an impact. There are also unintended consequences in product liability cases. Third party liability and subrogation may also be affected.

Continue ReadingExpert Witness for Future Medical Costs in Life Care Plans

Affordable Care Act Expert Witness Work Requires Attorney Education

In my work as an expert witness regarding the Patient Protection and Affordable Care Act (also known as the "ACA" or "Obamacare"), I find that more medical malpractice and personal industry cases as well as cases involving requirements for insurance coverage for self-insured employer's employees encompass ACA in their scope. The ACA may change the economics of healthcare as they apply to a legal matter involving damages, value of care, or insurance coverage and benefits.

Continue ReadingAffordable Care Act Expert Witness Work Requires Attorney Education

Drug Pricing Legislation and Inefficient Markets Theory

The inefficient markets theory is being reconsidered after the 2007 financial crisis in the U.S. Is it enough to provide the public with data on the cost of a service or alternative ways to purchase it? In healthcare the intersection of price, quality and sources of suppliers alone does not determine whether pricing is appropriate.

Continue ReadingDrug Pricing Legislation and Inefficient Markets Theory

Value Based Care Regulations Yield Physician Discontent, No Change in Behavior

Clinicians are in a knowledge management crisis – massive amounts of data but getting the right information to clinicians, IT personnel and others at the right time is the challenge. What was missing from the RAND report were biomedical informatics perspectives.

Continue ReadingValue Based Care Regulations Yield Physician Discontent, No Change in Behavior

Accountable Care Organization Medicare Shared Savings Progam

Accountable Care Organizations (ACOs) in the Medicare Shared Savings Program (MSSP) have a special, limited opportunity to innovate. Waivers exempting MSSP ACOs from certain legal requirements and other benefits enable MSSP ACOs to experiment within certain limits. The Medicare Shared Savings Program requires 33 measure that must be self-reported by the ACO to CMS. After a limited period, self-reporting will not be allowed and third parties will be required to perform reporting.

Continue ReadingAccountable Care Organization Medicare Shared Savings Progam